Zoloft formulary placement (correction)
Executive Summary
In a story on Medicare Part D formulary placement of antidepressants, "The Pink Sheet" incorrectly stated that Pfizer's Zoloft (sertraline) is not covered by Medco's YOURx Plan (1"The Pink Sheet" Dec. 19, 2005, p. 19). The agent is covered on Tier 2 of the plan's formulary with quantity limits. Consequently, Zoloft is covered on the lowest brand cost-sharing tier of five of the nine nationwide plans reviewed...
You may also be interested in...
Branded Antidepressants Face Challenges With Part D Formulary Positions
The Centers for Medicare & Medicaid Services appears to be interpreting its "all or substantially all" policy for Part D plan coverage of antidepressants as allowing sponsors to include the majority of agents on high cost-sharing tiers, according to analysis of plan formularies conducted by "The Pink Sheet."
The Top Five (Non-COVID) Pharma Stories Of 2020
The (virtual) doors closing on the J.P. Morgan Healthcare Conference is the sign for the biopharma industry that the new year has truly started, but before we get too far into 2021, Scrip has taken a look at five of the biggest non-COVID-19 story themes of 2020 in no particular order.
The Race To Vaccinate The World Against COVID-19
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: